Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche

被引:959
作者
Erler, Janine T. [1 ,2 ]
Bennewith, Kevin L. [1 ,3 ]
Cox, Thomas R. [2 ]
Lang, Georgina [2 ]
Bird, Demelza [2 ]
Koong, Albert [1 ]
Le, Quynh-Thu [1 ]
Giaccia, Amato J. [1 ]
机构
[1] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[2] Inst Canc Res, Chester Beatty Labs, Sect Cell & Mol Biol, London SW3 6JB, England
[3] British Columbia Canc Res Ctr, Dept Med Biophys, Vancouver, BC V5Z 1L3, Canada
关键词
MYELOID SUPPRESSOR-CELLS; TUMOR-BEARING HOST; IN-VITRO; IMMUNE SUPPRESSION; UP-REGULATION; IV-COLLAGEN; CANCER; METASTASIS; MACROPHAGES; INVASION;
D O I
10.1016/j.ccr.2008.11.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor cell metastasis is facilitated by "premetastatic niches" formed in destination organs by invading bone marrow-derived cells (BMDCs). Lysyl oxidase (LOX) is critical for premetastatic niche formation. LOX secreted by hypoxic breast tumor cells accumulates at premetastatic sites, crosslinks collagen IV in the basement membrane, and is essential for CD11b+ myeloid cell recruitment. CD11b+ cells adhere to crosslinked collagen IV and produce matrix metalloproteinase-2, which cleaves collagen, enhancing the invasion and recruitment of BMDCs and metastasizing tumor cells. LOX inhibition prevents CD11b+ cell recruitment and metastatic growth. CD11b+ cells and LOX also colocalize in biopsies of human metastases. Our findings demonstrate a critical role for LOX in premetastatic niche formation and support targeting LOX for the treatment and prevention of metastatic disease.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 40 条
  • [1] Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: Role of bone marrow-derived myelomonocytic cells
    Ahn, G-One
    Brown, J. Martin
    [J]. CANCER CELL, 2008, 13 (03) : 193 - 205
  • [2] Molecular mechanisms of tumor invasion and metastasis: An integrated view
    Cairns, RA
    Khokha, R
    Hill, RP
    [J]. CURRENT MOLECULAR MEDICINE, 2003, 3 (07) : 659 - 671
  • [3] CAMERON JD, 1991, INVEST OPHTH VIS SCI, V32, P2766
  • [4] Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3
    Caniggia, I
    Mostachfi, H
    Winter, J
    Gassmann, M
    Lye, SJ
    Kuliszewski, M
    Post, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (05) : 577 - 587
  • [5] Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
    Condeelis, J
    Pollard, JW
    [J]. CELL, 2006, 124 (02) : 263 - 266
  • [6] Inflammation and cancer
    Coussens, LM
    Werb, Z
    [J]. NATURE, 2002, 420 (6917) : 860 - 867
  • [7] DENHOLM EM, 1989, AM J PATHOL, V135, P571
  • [8] Investigating hypoxic tumor physiology through gene expression patterns
    Denko, NC
    Fontana, LA
    Hudson, KM
    Sutphin, PD
    Raychaudhuri, S
    Altman, R
    Giaccia, AJ
    [J]. ONCOGENE, 2003, 22 (37) : 5907 - 5914
  • [9] HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
    Du, Rose
    Lu, Kan V.
    Petritsch, Claudia
    Liu, Patty
    Ganss, Ruth
    Passegue, Emmanuelle
    Song, Hanqiu
    VandenBerg, Scott
    Johnson, Randall S.
    Werb, Zena
    Bergers, Gabriele
    [J]. CANCER CELL, 2008, 13 (03) : 206 - 220
  • [10] New functions for the matrix metalloproteinases in cancer progression
    Egeblad, M
    Werb, Z
    [J]. NATURE REVIEWS CANCER, 2002, 2 (03) : 161 - 174